Jing Xu1,2*, Yiran Gong1,2*, Kaiyi Yang1,2*, Yabin Fang1,2, Wenting Li1,2, Shuqiang Chen1,2,3

1Department of Ultrasound, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
2Department of Ultrasound, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou , China
3Department of Ultrasound, Fujian Provincial Hospital Affiliated to Fuzhou University, Fuzhou, China

Keywords: Arthritis, rheumatoid, semi-quantitative scoring, seronegative, ultrasonic.

Abstract

Objectives: This study aims to explore the value of ultrasonic semi-quantitative scoring in the diagnosis of seronegative rheumatoid arthritis (RA).

Patients and methods: Between January 2018 and October 2023, a total of 411 patients (241 males, 170 females; mean age: 50.9±17.5 years; range, 18 to 87 years) were included. Of these patients, 296 were diagnosed with RA (including 131 with seronegative RA [SNRA] and 165 with seropositive RA [SPRA]) and 115 with non-RA disease. Ultrasound examination was performed on all patients with suspected RA, focusing on evaluation of synovial hypertrophy (SH), power Doppler (PD) signals, and bone erosion (BE) for three to six months. The ultrasonic joint semi-quantitative score was evaluated for the sensitivity and specificity of detecting seronegative RA.

Results: The three indexes of SH, PD, and BE were not significantly different between the SNRA and SPRA groups (p=0.223, p=0.176; p=0.272, respectively). However, there were differences on the SH1, SH3, PD, and BE grades between the SNRA group and the non-RA group (p<0.001 for all); when serology was negative and when the highest scored joint met PD Grade ≥2 or BE Grade ≥2, it showed both high sensitivity (93.12%) and high specificity (91.30%) for the diagnosis of RA.

Conclusion: Ultrasound combined with semi-quantitative scoring is of promising significance in the early diagnosis of SNRA patients.

Citation: Xu J, Gong Y, Yang K, Fang Y, Li W, Chen S. A cohort study of ultrasonic semiquantitative scoring for the diagnosis of serology-negative rheumatoid arthritis. Arch Rheumatol 2024;39(4):579-587. doi: 10.46497/ ArchRheumatol.2024.10788.

Author Contributions

Contributed to conceptualization, data collection, data analysis, investigation, and manuscript writing: X.J., G.Y.R., Y.K.Y.; Contributed to conceptualization and ultrasound assessment: F.Y.B.; Contributed to data collection and data analysis: L.W.T.; Contributed to conceptualization, manuscript revision, funding acquisition, and supervision: C.S.Q.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

Please include the acknowledgment of financial support from the Social Development Guiding Project Fund of Fujian Province [Grant number 2021Y0012], the Fujian Province Joint Innovation and Dual High Project [Grant number 2021Y9092] and 2022 Medical University Transfer Financial Special Fund Project[Grant number 22SCZZX004].

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.